ENT Stock Overview
Engages in the exploration of mineral properties in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Enterprise Metals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.003 |
| 52 Week High | AU$0.005 |
| 52 Week Low | AU$0.002 |
| Beta | 1.23 |
| 11 Month Change | -25.00% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -76.92% |
| 5 Year Change | -66.67% |
| Change since IPO | -98.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| ENT | AU Metals and Mining | AU Market | |
|---|---|---|---|
| 7D | -40.0% | 1.6% | 0.9% |
| 1Y | 0% | -10.8% | 18.4% |
Return vs Industry: ENT exceeded the Australian Metals and Mining industry which returned -10.8% over the past year.
Return vs Market: ENT underperformed the Australian Market which returned 18.4% over the past year.
Price Volatility
| ENT volatility | |
|---|---|
| ENT Average Weekly Movement | n/a |
| Metals and Mining Industry Average Movement | 11.0% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: ENT's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine ENT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | n/a | www.enterprisemetals.com.au |
Enterprise Metals Limited engages in the exploration of mineral properties in Australia. It primarily explores for copper, gold, nickel, zinc, iron ore, titanium, heavy minerals, lithium, rare earths, and base metals. The company was formerly known as Revere Mining Limited and changed its name to Enterprise Metals Limited in December 2008.
Enterprise Metals Limited Fundamentals Summary
| ENT fundamental statistics | |
|---|---|
| Market cap | AU$3.31m |
| Earnings (TTM) | -AU$1.17m |
| Revenue (TTM) | AU$65.18k |
50.8x
P/S Ratio-2.8x
P/E RatioIs ENT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENT income statement (TTM) | |
|---|---|
| Revenue | AU$65.18k |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$65.18k |
| Other Expenses | AU$1.24m |
| Earnings | -AU$1.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0011 |
| Gross Margin | 100.00% |
| Net Profit Margin | -1,795.53% |
| Debt/Equity Ratio | 0% |
How did ENT perform over the long term?
See historical performance and comparison